31 March 2023
SHARE NOW
ATW
Cell Therapy
Clinical Trials
Collaborations, Mergers & Acquisitions
Gene Therapy
Partnering
Scaling Up
Strategy
This Briefing from Advanced Therapies Week 2023 focusses on the optimization of lentivirus capture and polishing steps.
During this session, Cytiva’s Michelle Hutchinson is joined by Åsa Hagner Mcwhirter and Adam Mcleod – also from Cytiva – as well as James Miskin from Oxford Biomedica.
This Briefing was presented at Advanced Therapies Week 2023, in partnership with Cytiva.
More like this
Eureka Therapeutics Awarded $10.6M CIRM Grant for T-Cell Therapy in Pediatric Liver Cancer
Eureka Therapeutics has received a $10.6 million grant from the California Institute for Regenerative Medicine (CIRM) to support its ongoing ARYA-2 Phase I study of ET140203 for the treatment of refractory/relapsed liver cancer for pediatric patients.
8 June 2023
Cell and Gene Therapy Catapult Open New Edinburgh, UK, Facilities
UK-based independent innovation and technology organization Cell and Gene Therapy Catapult (CGT Catapult), has officially opened new laboratories and offices in Edinburgh, Scotland, UK, BioQuarter – enhancing Edinburgh’s role as a hub for cell therapies.
7 June 2023
BioCentriq® Unveils LEAP™ Advanced Therapy Platform, Enabling Rapid Patient Access for Early-Stage Biotech Companies
BioCentriq launched their new LEAP™ Advanced Therapy Platform at the 29th International Society for Cell & Gene Therapy (ISCT) annual event with proven assets and expertise to help early-stage biotech companies effectively deliver to patients without compromising quality.
5 June 2023
Discover more like this
